Compare Quest Diagnostics Inc (DGX) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? Quest Diagnostics Inc trades at $230.9 (market cap $25.48B), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $25.43 (market cap $141.25M). The key difference: Quest Diagnostics Inc is far larger — about 180.4× ProShares UltraShort Bloomberg Natural Gas ETF's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while ProShares UltraShort Bloomberg Natural Gas ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and ProShares UltraShort Bloomberg Natural Gas ETF for 10 Days on average.
| DGX | KOLD | |
|---|---|---|
Market Cap | $25.48B | $141.25M |
Volume | 941,866 | 5,492,367 |
Sector | Health | Leveraged / Inverse |
52-Week High | $247.45 | $49.39 |
52-Week Low | $173.49 | $13.58 |
Typical Hold Time | 56 Days | 10 Days |
Enterprise Value | $31.23B | — |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $227.00, down 0.64% on the day, with the stock showing strong fundamental performance including three consecutive quarterly earnings beats and revenue growth from $9.9B in 2024 to $11.04B in 2025. Technical indicators signal bearish momentum with the current price near key support at $226, while the company maintains solid profitability with 9.19% net income margin and 14.35% ROE. Recent developments include positive clinical study results and a new partnership with Apple Health app for lab testing integration.
The investment outlook remains positive with analyst consensus target of $250 representing 10% upside potential, though Medicare reimbursement cuts pose near-term headwinds. Growth drivers include advanced diagnostics expansion and consumer testing demand, balanced against technical weakness and regulatory uncertainty. The stock offers value with reasonable P/E of 24.1 and consistent dividend payments.
KOLD is trading at $24.84, down 5.8% over the past 24 hours amid bearish technical signals. The stock faces significant selling pressure with moving averages indicating a strong downtrend, though oscillators remain neutral. Recent news highlights natural gas market volatility with record production levels and geopolitical tensions affecting energy sector sentiment. The stock currently trades near key support levels with resistance forming around $25-26.
The outlook remains challenging with bearish technical indicators and fundamental headwinds in the natural gas sector. Investment opportunities exist for contrarian investors betting on energy market recovery, but risks include continued production growth and weather-dependent demand. The stock's performance will likely track natural gas price movements and broader energy market dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →
